Home				Neurodegenerative Diseases Tx/Dx CI - Y2006 week 43
DATE	SOURCE	OTHER PARTY INVOLVED	INDICATION(S)	HEADLINES - CLICK TO VIEW FULL RELEASE
10/27/06	Schwarz Pharma (DE)		Parkinson	Nine Months Report 2006: Business on Track, Further Progress in R&D
10/27/06	Shire (UK)	Janssen Pharmaceutical (US)	Alzheimer	Excellent third quarter with execution plan on track - upgrading 2006 revenue guidance
10/25/06	Elan (IR)		Various	Elan Reports Third Quarter 2006 Financial Results
10/24/06	Tiantan Puhua Neurosurgical Hospital (CN)		Parkinson	Stem Cell Treatment Proven to Reduce Parkinson's Symptoms
10/23/06	Berlex (US)	Schering (DE)	Multiple sclerosis	FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple Sclerosis
10/23/06	Schering (DE)	Berlex (US)	Multiple sclerosis	Betaseron approved in the U.S. for earliest stages of Multiple Sclerosis